Losartan and Paclitaxel in PROC

• Status: NOT_YET_RECRUITING
• Trial end date: 2028-12-30

Summary

The purpose of this Phase II study is to measure the effects of a combination of study drugs, losartan and paclitaxel, on platinum resistant ovarian cancer.

• Phase: PHASE2

Details

• Lead Sponsor: Massachusetts General Hospital
• Collaborator: American Cancer Society, Inc.
• Treatments: Losartan; Paclitaxel